3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Schwannomatosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Neurilemmoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Cytokine Release Syndrome
1
Chronic Pain
1
Burkitt Lymphoma
1
Interventions
Lenalidomide
6
Dexamethasone
6
Cyclophosphamide
5
Bortezomib
5
fludarabine
3
carfilzomib
3
belantamab mafodotin
3
pomalidomide
2
fludarabine phosphate
2
Melphalan
2
Etoposide
2
pembrolizumab
1
isatuximab
1
elotuzumab
1
daratumumab
1
Whole-Body Irradiation
1
Thalidomide
1
Tacrolimus
1
Sirolimus
1
Resistance Training
1
Radiotherapy
1
Pharmaceutical Preparations
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Methotrexate
1
Exercise
1
Equipment and Supplies
1
Doxorubicin
1
Cyclosporine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Plasma Cell
×
siltuximab
×
90 days
×
Clear all
No trials found.